BRIGHTCOVE (BCOV)
US10921T1016 - Common Stock
BCOV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 86 industry peers in the IT Services industry. The financial health of BCOV is average, but there are quite some concerns on its profitability. BCOV does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year BCOV has reported negative net income.
In the past year BCOV had a positive cash flow from operations.
In the past 5 years BCOV reported 4 times negative net income.
BCOV had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
BCOV's Return On Assets of -10.59% is on the low side compared to the rest of the industry. BCOV is outperformed by 70.24% of its industry peers.
With a Return On Equity value of -24.37%, BCOV is not doing good in the industry: 63.10% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.59% | ||
| ROE | -24.37% | ||
| ROIC | N/A |
ROA(3y)-4.02%
ROA(5y)-5.56%
ROE(3y)-9.19%
ROE(5y)-12.88%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of BCOV (61.56%) is better than 79.76% of its industry peers.
BCOV's Gross Margin has been stable in the last couple of years.
BCOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.56% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.65%
2. Health
2.1 Basic Checks
BCOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BCOV has more shares outstanding
BCOV has more shares outstanding than it did 5 years ago.
BCOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
BCOV has an Altman-Z score of -0.73. This is a bad value and indicates that BCOV is not financially healthy and even has some risk of bankruptcy.
BCOV has a worse Altman-Z score (-0.73) than 78.57% of its industry peers.
BCOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.73 |
ROIC/WACCN/A
WACC10.95%
2.3 Liquidity
BCOV has a Current Ratio of 0.67. This is a bad value and indicates that BCOV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.67, BCOV is not doing good in the industry: 89.29% of the companies in the same industry are doing better.
A Quick Ratio of 0.67 indicates that BCOV may have some problems paying its short term obligations.
BCOV has a worse Quick ratio (0.67) than 89.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.67 |
3. Growth
3.1 Past
The earnings per share for BCOV have decreased strongly by -121.74% in the last year.
Looking at the last year, BCOV shows a decrease in Revenue. The Revenue has decreased by -4.66% in the last year.
The Revenue has been growing slightly by 4.07% on average over the past years.
EPS 1Y (TTM)-121.74%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q300%
Revenue 1Y (TTM)-4.66%
Revenue growth 3Y0.64%
Revenue growth 5Y4.07%
Revenue growth Q2Q1.86%
3.2 Future
Based on estimates for the next years, BCOV will show a very strong growth in Earnings Per Share. The EPS will grow by 34.01% on average per year.
BCOV is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.23% yearly.
EPS Next Y-63.2%
EPS Next 2Y34.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.04%
Revenue Next 2Y-0.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
BCOV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BCOV. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as BCOV's earnings are expected to grow with 34.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.01%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for BCOV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BRIGHTCOVE
NASDAQ:BCOV (4/24/2024, 7:00:01 PM)
After market: 1.73 +0.08 (+4.85%)1.65
-0.03 (-1.79%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap73.28M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.59% | ||
| ROE | -24.37% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 61.56% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.67 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-121.74%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-63.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-4.66%
Revenue growth 3Y0.64%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y